Search

Researchers from the Chinese Academy of Medical Sciences conducted a prospective cohort study to investigate the incidence of active tuberculosis (TB) in patients with Takayasu's Arteritis (TAK) and the impact of anti-rheumatic therapy on TB occurrence. The study found that patients with TAK are at a high risk of developing TB, with the use of tumour necrosis factor inhibitor (TNFi) increasing the risk of TB in patients with latent TB infection. Glucocorticoids and conventional disease-modifying anti-rheumatic drugs (cDMARDs) did not significantly increase the risk of TB in patients with TAK. The study also noted that interferon-gamma release assay (IGRA) may have limited effectiveness in monitoring TB infection or latent TB reactivation in patients with TAK. [Extracted from the article]

Researchers at a Radiology Department discussed a case of Takayasu's arteritis causing coronary stenosis with myocardial ischemia, severe aortic regurgitation, and pericarditis. The study emphasized the importance of early diagnosis and multimodal imaging in managing this rare large-vessel vasculitis that can lead to severe cardiac complications. The case study highlighted the need to consider Takayasu's arteritis in patients with atypical clinical features and cardiac involvement, particularly in cases with valvular disease. For more information, readers can refer to the Radiology Case Reports journal article. [Extracted from the article]

A recent study conducted in Henan, People's Republic of China, focused on Takayasu's Arteritis, a rare systemic macrovasculitis in children that can lead to organ dysfunction. The research highlighted a case of an 11-year-old girl with TA-induced thrombosis in the right middle cerebral artery, which was successfully treated with transcatheter thrombolysis. The study emphasized the importance of early diagnosis and treatment in pediatric TA cases to prevent organ damage and ensure favorable outcomes. The research concluded that transcatheter thrombolysis effectively restores brain perfusion in cases of acute cerebral infarction. [Extracted from the article]

A case report from University College Hospital in Nigeria discusses a rare instance of Takayasu arteritis leading to acute ischemic stroke and anterior ischemic optic neuropathy in a 33-year-old woman. The patient presented with weakness in her right extremities and painless vision loss in her left eye, along with other symptoms. Treatment with prednisolone, azathioprine, and secondary stroke preventive care resulted in improved vision and functional outcomes. The research emphasizes the importance of recognizing the diverse clinical presentations of Takayasu arteritis to prevent adverse cardiovascular complications. [Extracted from the article]

A recent study from University Hospital in Tunis, Tunisia, highlights the effectiveness of anti-IL-6R therapy, specifically tocilizumab, in treating Takayasu's arteritis. The case study of a 34-year-old patient with refractory Takayasu arteritis showed significant improvement after receiving anti-IL-6R infusions, leading to a complete resolution of symptoms. This research underscores the potential of anti-IL-6R as a promising therapeutic option for Takayasu's arteritis, particularly in cases that are resistant to traditional treatments. [Extracted from the article]

A recent study conducted at Hospital Universitario Professor Edgard Santos in Brazil explored the association between Takayasu's arteritis (TA) and tuberculosis (TB). The research found that patients with TA and a history of TB exhibited more constitutional symptoms and structural damage to the aorta. The study compared clinical and radiological features of patients with TA with and without active TB or latent TB infection (LTBI), revealing a higher prevalence of dilatation and aneurysms in the abdominal aorta among patients with TA and TB. The findings suggest a potential link between TA and TB, highlighting the importance of further research in this area. [Extracted from the article]

Researchers at Iran University of Medical Sciences presented a challenging case of Takayasu's arteritis in a 17-year-old male with various manifestations and a poor outcome. The patient exhibited symptoms such as dyspnea, fever, arm claudication, and aortic insufficiency, leading to a diagnosis of Takayasu's arteritis. Unfortunately, the patient passed away after six months of treatment, succumbing to a COVID-19 infection. The study provides valuable insights into the complexities of this rare vascular disease. [Extracted from the article]

A recent study from the Graduate School of Medicine in Osaka, Japan, focused on a 46-year-old woman with Takayasu arteritis, severe stenosis in the left main coronary artery, and severe aortic regurgitation. The patient received prednisolone and tacrolimus as treatments, leading to an improvement in aortic regurgitation severity. The research suggests that surgical management of the coronary artery in Takayasu arteritis patients with severe left main coronary artery stenosis should be considered after successful anti-inflammatory therapy. [Extracted from the article]

Researchers from the University of Baghdad have published a case report on a 33-year-old man with Takayasu's arteritis, a rare inflammatory disease affecting the aorta and its branches. The patient presented with inflammatory back pain, chest pain, and other symptoms, leading to a diagnosis of Takayasu arteritis. Treatment with various medications, including steroids and biologics, resulted in symptomatic improvement. The study highlights the importance of considering inflammatory aortitis in the assessment of inflammatory back pain to avoid delays in diagnosis. [Extracted from the article]

Researchers from the Faculty of Medicine in Yogyakarta, Indonesia, have published a study on Takayasu's arteritis, a rare chronic granulomatous vasculitis that mainly affects the aorta and its main branches. The study focuses on two cases of children with undetected Takayasu arteritis presenting as severe hypertension, highlighting the challenges of diagnosing this condition in its early stages. The research emphasizes the significant morbidity and mortality associated with childhood-onset Takayasu's arteritis. For more information, the full article can be accessed through Paediatrica Indonesiana. [Extracted from the article]

University of Iowa researchers have conducted studies on giant cell arteritis and Takayasu's arteritis, focusing on the role of imaging in diagnosis. Recent advancements in diagnostic imaging for large vessel vasculitis, including the use of ultrasound and MRI, have led to earlier diagnosis and improved treatment outcomes. The research highlights innovative imaging technologies such as contrast-enhanced ultrasound, shear wave elastography, and the integration of PET with MRI, aiming to enhance diagnostic precision in the future. [Extracted from the article]

A recent study conducted at the University of Yamanashi Hospital in Japan focused on the imaging findings of large-vessel vasculitis (LVV) in patients with giant cell arteritis (GCA) and Takayasu arteritis (TAK). The research highlighted the importance of distinguishing between acute-phase findings (activity) and chronic-phase findings (damage) in assessing disease progression and treatment outcomes. The study found that wall thickening and wall contrast enhancement improved after treatment, especially in the GCA group, while stenosis, occlusion, dilation, aneurysm, and calcification were more common chronic-phase findings. The research provides valuable insights into the differences between GCA and TAK in terms of imaging characteristics and disease manifestations. [Extracted from the article]

Researchers at Beijing Hospital in China conducted a study on patients with Takayasu's arteritis undergoing open or endovascular operations. The study found that the majority of patients were female, with hypertension being the most common vascular finding. The subclavian, carotid, and renal arteries were the most commonly involved arteries, with type V being the most common angiographic classification pattern. The research concluded that variations in angiographic features can impact clinical manifestations and the possibility of operations. [Extracted from the article]

A recent study conducted at Rutgers University Robert Wood Johnson Medical School focused on Takayasu's Arteritis, a rare inflammatory large-vessel vasculitis that affects the aorta and its branches, including the cerebrovascular system. The study analyzed patient outcomes and treatment options, highlighting a female predominance in patients and the impact of different interventions on disease management. The research emphasizes the importance of assessing disease activity in planning vascular interventions and the need for continued research to improve patient outcomes. [Extracted from the article]

Researchers from Freeman Health System have reported on findings regarding Takayasu's Arteritis, a large-vessel vasculitis that primarily affects women of childbearing age. The study focused on a case of Takayasu arteritis with high-grade stenosis of the thoracic great vessels of the aorta, which was treated with drug-coated balloon angioplasty and stenting over a 1-year follow-up period. The research suggests that drug-coated balloon angioplasty could be a potential endovascular treatment for thoracic great artery stenosis in Takayasu arteritis, warranting further exploration. [Extracted from the article]

A new report discusses research findings on Takayasu's arteritis, a vascular disease. The study aimed to investigate the prevalence and characteristics of late gadolinium enhancement (LGE) by cardiac magnetic resonance (CMR) and its prognostic value in patients with Takayasu arteritis. The study found that LGE-positive patients had adverse left ventricular (LV) remodeling and worsened cardiac function. However, the strongest independent predictor of primary outcomes in patients with Takayasu arteritis was LV mass index (LVMI), rather than LGE. This research provides valuable insights into the cardiac structure and function in patients with Takayasu arteritis. [Extracted from the article]

Researchers from Peking Union Medical College in Beijing, China have conducted a study on Takayasu's Arteritis, a cardiovascular disease. The study aimed to explore the value of monitoring serum interleukin-6 (IL-6) levels in predicting the effectiveness and safety of tocilizumab (TCZ) treatment in refractory Takayasu arteritis (TAK). The study found that the change in IL-6 levels after 6 months of TCZ treatment compared to the baseline can predict the overall treatment response at 12 months, 24 months, and sustained improvement. The study did not find a correlation between IL-6 dynamics and the occurrence of adverse events. [Extracted from the article]

A recent study conducted at the Affiliated Hospital of Qingdao University in China provides new insights into Takayasu's arteritis, a primary systemic vasculitis that affects large blood vessels. The study focuses on a case of an adolescent female patient who initially experienced numbness and weakness in her limbs, which later developed into severe hypertension. The patient was diagnosed with Takayasu's arteritis and subsequently experienced multiple cerebral hemorrhages. After surgery and treatment with tocilizumab, the patient's condition improved. The researchers recommend considering Takayasu's arteritis when evaluating hypertension in young patients and emphasize the importance of timely diagnosis and standardized treatment. [Extracted from the article]

Researchers at the Sri Jayadeva Institute of Cardiovascular Sciences and Research have discovered a rare case of left ventricular apical aneurysm in a 37-year-old woman with Takayasu arteritis (TA) and normal epicardial coronaries. TA is a chronic inflammatory disease characterized by large vessel vasculitis involving the aorta and its branches. The patient also had concomitant chronic active Epstein-Barr virus infection, which potentially exacerbated the inflammatory process in TA and complicated management and patient outcomes. This finding highlights the importance of considering viral infections in the context of cardiovascular diseases. [Extracted from the article]

Researchers from the University of California Los Angeles (UCLA) conducted a study on Takayasu's Arteritis (TAK), a cardiovascular disease. The study involved 236 patients with TAK, with 89% of them showing damage in the peripheral vascular and cardiac systems. During the follow-up period, 42% of patients experienced new damage, including major vessel stenosis/arterial occlusion, limb claudication, hypertension, aortic aneurysm, and bypass surgery. The researchers concluded that therapies for TAK should prioritize controlling disease activity and preventing damage. This research has been peer-reviewed and published in Rheumatology. [Extracted from the article]

The article focuses on new findings regarding Takayasu's arteritis, comparing two cases with different clinical presentations and treatment responses. Topics include the contrasting symptoms and imaging findings in the two patients, the varying timelines for treatment efficacy, and the importance of early diagnosis and imaging for managing this rare condition.

The article discusses research by Sameen Aamer and colleagues, reported in the European Journal of Case Reports in Internal Medicine issue on August 19, 2024. The study explores the association between Takayasu's arteritis (TA) and membranous nephropathy (MN), with topics including the presentation of MN before TA, the diagnostic challenges of TA in patients with MN, and the unique case of a young female with THSD7A-positive MN.

A new report from the School of Medicine discusses a rare and complex case of Takayasu's arteritis, a large vessel vasculitis that primarily affects young females. Unlike typical cases, this 34-year-old male presented with an unusually high number of aneurysms affecting the aorta, subclavian arteries, and other segments. Managing multiple aneurysms in Takayasu's arteritis is complex and requires careful consideration of factors such as aneurysm size, morphology, and risk of complications. This case highlights the need for a comprehensive approach to treatment. [Extracted from the article]

A recent study conducted by researchers from the Federal University Sao Paulo in Brazil examined the role of effector CD4+ T cells in Takayasu's Arteritis (TAK), a granulomatous vasculitis that affects large arteries. The study included 30 TAK patients and 30 controls, and found that TAK patients had lower levels of CD3+ T cells and CD4+ T cells compared to controls. Additionally, patients with active disease and those in remission had higher proportions of Th17 cells. The study also analyzed the expression of certain markers in the aorta and found that CD8 cells and the Th2 response were predominant. This research provides insights into the immune response in TAK and may contribute to the development of targeted therapies. [Extracted from the article]

A recent study from Jawaharlal Nehru Medical College in Maharashtra, India, has provided new insights into Takayasu's arteritis, a chronic inflammatory disease that affects large blood vessels. The study highlights the rare manifestation of gangrene in Takayasu's arteritis, with a case report of a 32-year-old female who presented with gangrene and a history of rheumatoid arthritis. The researchers emphasize the importance of early diagnosis and intervention in managing Takayasu's arteritis to prevent adverse outcomes and reduce the financial, social, and psychological consequences. The study concludes that timely intervention, such as below-knee amputation and medical management, is crucial in treating gangrene associated with Takayasu's arteritis. [Extracted from the article]

A recent report from the Institute for Cancer Research and Treatment (IRCCS) in Reggio Emilia, Italy, discusses the use of ultrasound examination to differentiate between Takayasu arteritis (TAK) and large vessel giant cell arteritis (LV-GCA). The study found that the thickness of the adventitial layer in the common carotid artery was significantly higher in TAK patients compared to LV-GCA patients. An adventitial thickness greater than 0.76 mm was found to be a reliable indicator of TAK. The research suggests that ultrasound examination of adventitial thickness can be a useful tool in distinguishing between these two conditions. [Extracted from the article]

A recent study conducted at Peking Union Medical College Hospital in Beijing, China has provided new information about Takayasu's Arteritis, a condition characterized by arterial wall inflammation and remodeling. The researchers found that vascular smooth muscle cells (VSMCs) play a significant role in the inflammation and contribute to vascular inflammation by upregulating the expression of senescence-associated inflammatory cytokines. The study also identified IL-6 as a critical cytokine that drives VSMCs senescence and senescence-associated mitochondrial dysfunction in Takayasu's Arteritis. The findings suggest that VSMCs senescence is actively involved in vascular inflammation in this condition. [Extracted from the article]

A recent study conducted at the Christian Medical College in Tamil Nadu, India, explored the genetics and pathogenesis of childhood-onset Takayasu arteritis (pTA). The researchers hypothesized that South Asian patients with pTA may have unique pathogenic variants involving genes linked to vasculitic illnesses. The study included 14 children with pTA, and whole exome sequencing revealed novel variants in genes related to the classical complement pathway, collagen, and autoinflammatory pathways. The findings suggest that digenic inheritance involving heterozygous variants in C3 and COL5A1 may contribute to disease development in some patients with pTA. [Extracted from the article]

A new study on Takayasu's arteritis, a rare inflammatory disease that affects the blood vessels, has found a potential association between the disease and ulcerative colitis (UC). The study investigated the presence of anti-integrin avb6 antibody in Takayasu's arteritis patients with and without UC. The results showed that the antibody was more prevalent in patients with UC compared to those without UC. The study suggests that there may be shared underlying pathologic mechanisms between Takayasu's arteritis and UC. Further research is needed to understand the relationship between these two conditions. [Extracted from the article]

A patent application titled "Pharmaceutical Composition For Preventing Cytokine Storm" has been published online by the US Patent and Trademark Office. The patent application, filed by inventors from Kinki University in Japan, describes compounds that inhibit the activation of the NF-kB pathway and suppress the production of inflammatory cytokines such as TNFa and IL-6. These compounds have the potential to prevent cytokine storms, which are associated with severe respiratory distress and organ failure in diseases such as COVID-19, sepsis, and influenza. The pharmaceutical compositions could be administered orally, providing a potential treatment option for patients who cannot receive immediate medical care. [Extracted from the article]

A recent study conducted by the University of Paris compared the clinical spectrum and outcomes of Takayasu's arteritis (TAK) in adults and children in a European population. The study found that children with TAK presented with more systemic symptoms such as fever, fatigue, and weight loss, while adults had more upper limb claudication. The topography of the lesions also differed between the two groups, with adults having more damage in the cerebral vasculature and limbs, while children had more kidney lesions. Children with TAK had more frequent and severe inflammation, received higher doses of corticosteroids, and had higher rates of relapse and death compared to adults. The study suggests that pediatric patients may require closer monitoring and systemic use of biological treatment. [Extracted from the article]

A recent study conducted by the National Institutes of Arthritis and Musculoskeletal and Skin Diseases in Bethesda, Maryland, provides new insights into Giant Cell Arteritis (GCA) and its association with clonal hematopoiesis (CH). The study found that CH, characterized by somatic mutations in hematopoietic cells, was detected in 34% of patients with GCA, compared to 18% of age-matched controls. The prevalence of CH was independently associated with age and vasculitis, occurring most frequently in patients with GCA. The research suggests that while CH may contribute to inflammation, it is not likely a primary causal factor in systemic vasculitis. [Extracted from the article]

A recent report from Jimma University discusses a case of Takayasu's arteritis, a rare large-vessel vasculitis, in a 25-year-old woman from Ethiopia. The woman initially presented with an ischemic stroke and was later diagnosed with Takayasu's arteritis based on angiography and clinical criteria. The case highlights the importance of considering Takayasu's arteritis as a potential cause of stroke in young patients, even in the absence of traditional risk factors. The researchers emphasize the need for appropriate testing and modified management for early diagnosis and treatment. [Extracted from the article]

A new report from Kyoto University discusses research findings on brain ischemia in Takayasu arteritis, a disease that primarily affects young women and damages large arteries and organs. The study examined the impact of disease duration and sex on organ damage and quality of life using Japan's Intractable Disease Registry. The research found that longer disease duration was associated with a lower prevalence of disease activity symptoms, a higher prevalence of organ damage, and a higher proportion of patients requiring nursing care. Women tended to have an earlier onset age and longer disease duration, and a higher proportion of women had aortic regurgitation and required nursing care. The study suggests that early diagnosis and effective treatment, particularly to prevent brain ischemia, visual impairment, and ischemic heart disease, may improve the quality of life of patients with Takayasu arteritis, especially women. [Extracted from the article]

A recent study on Takayasu's arteritis, a rare type of vasculitis, has been published. The study highlights the severe complications associated with the disease, including stroke, ischemic heart disease, pulmonary hypertension, secondary hypertension, and aneurysms. Diagnosis is typically made using clinical and angiographic criteria. The study presents a case report of a 34-year-old woman with Takayasu's arteritis who experienced multiple arterial complications over the years. The patient received medical and surgical treatment, including immunosuppressive medication and surgical therapy. The study emphasizes the limited outcomes of current treatments for Takayasu's arteritis. [Extracted from the article]

A retrospective study conducted in Malaysia analyzed the clinical characteristics, angiographic involvement patterns, and outcomes of Takayasu's Arteritis (TA) in Malaysian patients over a period of three decades. The study found that TA predominantly affected females, with a female-to-male ratio of 13.1:1, and had an average age of onset of 27.47 years. The most common comorbidity observed was hypertension, followed by dyslipidemia. The study also revealed that the most prevalent angiographic pattern was Type V, with the left subclavian artery and left carotid being the most commonly involved vessels. The research contributes to a better understanding of TA in Malaysia and provides insights for improved management of TA patients in the country. [Extracted from the article]

A report from the Connective Tissue Diseases Research Center discusses a rare case of a 44-year-old female who was diagnosed with both ulcerative colitis (UC) and Takayasu arteritis (TAK). The patient experienced an unusual asymptomatic onset of symptoms accompanied by neurological complications, including acute ischemic stroke and vascular abnormalities. The case highlights the importance of an integrated diagnostic approach for overlapping autoimmune conditions and emphasizes the complexity involved in diagnosing and treating these conditions. The report contributes to the limited literature on this topic and underscores the need for early detection and comprehensive treatment approaches. [Extracted from the article]

A new report discusses research on Takayasu's arteritis, a condition that affects the blood vessels. The study aimed to compare the effectiveness and safety of two treatments, adalimumab and leflunomide, in patients with Takayasu's arteritis. The study found that both treatments had similar outcomes after 15 months of follow-up. However, only the leflunomide group experienced withdrawal from therapy and mild-to-moderate adverse events. This research provides valuable information for healthcare professionals and patients seeking treatment options for Takayasu's arteritis. [Extracted from the article]

A clinical trial, NCT06289738, has been launched to analyze the problem in patients with Takayasu Arteritis based on the International Classification of Functioning, Disability and Health. The study will include individuals between the ages of 18-65 who have been diagnosed with Takayasu Arteritis by rheumatologists and are followed by Pamukkale University Rheumatology Clinic. The trial is currently recruiting participants in Turkey and is expected to be completed by March 25, 2024. [Extracted from the article]

A recent report from the City University of New York (CUNY) provides new insights into central nervous system disorders, specifically systemic vasculitis and headache. Vasculitis refers to inflammation of blood vessels and can lead to injury and disability if left untreated. Headache is an important clue to vasculitic involvement of the central nervous system (CNS). Prompt evaluation and treatment are necessary to prevent progression and cerebral ischemia or infarction. The report highlights progress in the pathogenesis, diagnosis, and treatment of primary adult and pediatric CNS vasculitides. [Extracted from the article]

A study conducted by researchers at Capital Medical University in Beijing, China, has found that decreased levels of the cytokine IL-4 may be a risk factor for depression in patients with Takayasu's arteritis (TA). The study analyzed serum cytokine levels in 40 TA patients and 11 healthy controls, and found that TA patients with depression had lower levels of IL-4 compared to non-depressed patients. The researchers suggest that IL-4 level testing could be used as a potential indicator of depression in TA patients. This research provides valuable insights into the relationship between immune system disorders and depression in TA patients. [Extracted from the article]

Researchers from An-Najah National University have published a case report on Takayasu's arteritis, a chronic inflammatory arteritis of large vessels. The report describes the case of a 20-year-old female patient who initially presented with a persistent cough. Despite multiple visits to seek medical help and taking antibiotics, her symptoms did not improve. Further investigations revealed thickening of the descending thoracic aorta, indicating an underlying chronic granulomatous vasculitis. The patient was treated with corticosteroids and azathioprine, which resulted in significant improvement. The researchers emphasize the importance of considering atypical symptoms and late-onset vascular symptoms in order to detect complications early. [Extracted from the article]

A study conducted by researchers at the Leibniz German Rheumatism Research Centre in Berlin, Germany, aimed to examine the current care situation of patients with giant cell arteritis (GCA), Takayasu arteritis (TAK), ANCA-associated vasculitis (AAV), and Behcet's disease (BD). The study analyzed data from the German National Database of the Collaborative Arthritis Centres between 2007 and 2021, comparing medication, disease activity, inpatient stays, and employment rates for different vasculitis entities over time. The findings revealed a decrease in glucocorticoid use and an increase in biologic therapies, while patient-reported outcomes remained largely unchanged. Although work participation increased, it still remained lower than that of the German population. [Extracted from the article]

A recent study conducted by researchers at the Instituto Nacional de Pediatria in Mexico City has found that visual disturbances, such as blindness, can be an initial symptom of Takayasu's Arteritis (TA) in children. The study reviewed cases of vision loss before or at the time of TA diagnosis and identified two children who presented with amaurosis, a condition characterized by transient or permanent vision loss. Both patients had significant head and neck vascular alterations and responded well to corticosteroids and immunosuppressant therapy. The researchers concluded that vision loss should alert physicians to consider TA in their differential diagnosis. [Extracted from the article]

A recent study conducted at Henan Province People's Hospital in Zhengzhou, People's Republic of China, focused on Takayasu's Arteritis, a chronic vasculitis that affects the aorta and its major branches. The researchers found that Takayasu's Arteritis can be associated with secondary hypertension caused by renovascular disease and hyperthyroidism. The study presented a case of an 18-year-old female with Takayasu's Arteritis and hyperthyroidism, who experienced symptoms such as fatigue and palpitations. The researchers emphasized the importance of early diagnosis and treatment for better prognosis. Further research is needed to explore the potential correlation between Takayasu's Arteritis and hyperthyroidism. [Extracted from the article]